HARROW HEALTH, INC. Business Finance Contracts & Agreements

93 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Harrow Health, Inc. Common Stock Underwriting Agreement with B. Riley Securities, Inc. (July 18, 2023)
Underwriting Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2023
Harrow Health, Inc. 11.875% Senior Notes Due 2027 Underwriting Agreement with B. Riley Securities, Inc.
Underwriting Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2022
Harrow Health, Inc. Common Stock Underwriting Agreement with B. Riley Securities, Inc.
Underwriting Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2022
Description of Securities Registered Under Section 12 of the Exchange Act – Harrow Health, Inc.
Equity Distribution Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2022
Harrow Health, Inc. 8.625% Senior Notes Due 2026 Underwriting Agreement with B. Riley Securities, Inc.
Underwriting Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2021
Harrow Health, Inc. 8.625% Senior Notes Due 2026 Underwriting Agreement with B. Riley Securities, Inc.
Underwriting Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2021
Eton Pharmaceuticals, Inc. Underwriting Agreement with National Securities Corporation and Harrow Health, Inc.
Underwriting Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2021
Description of Harrow Health, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2021
Description of Harrow Health, Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2020
Secured Promissory Note between Park Compounding, Inc. and Noice Rx, LLC dated July 26, 2019
Note Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2019
Asset Purchase Agreement between Elle Pharmaceutical, LLC and Harrow Health, Inc. dated February 1, 2019
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2019
Asset Purchase Agreement between Harrow Health, Inc. and Mayfield Pharmaceuticals, Inc. dated February 1, 2019
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2019
Asset Purchase Agreement between Imprimis Pharmaceuticals, Inc. and Melt Pharmaceuticals, Inc.
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2019
Amended and Restated Asset Purchase and License Agreement between Imprimis Pharmaceuticals, Inc. and Surface Pharmaceuticals, Inc.
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2018
Description of Harrow, Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Stock Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2024
Loan and Security Agreement among Harrow Health, Inc., Subsidiaries, Lenders, and B. Riley Commercial Capital, LLC (December 2022)
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2023
Description of Securities Registered Under Section 12 of the Exchange Act – Harrow Health, Inc.
Stock Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2023
Second Supplemental Indenture to 11.875% Senior Notes Due 2027 between Harrow Health, Inc. and U.S. Bank Trust Company, N.A.
Indenture Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2022
Asset Purchase Agreement among Novartis Technology LLC, Novartis Innovative Therapies AG, and Harrow Health, Inc. (and Affiliates) dated December 13, 2022
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2022
Second Amendment to Loan and Security Agreement by and among Harrow Health, Inc., Melt Pharmaceuticals, Inc., and Guarantors
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2022
First Amendment to Loan and Security Agreement between Harrow Health, Inc. and Melt Pharmaceuticals, Inc.
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2022
Loan and Security Agreement between Melt Pharmaceuticals, Inc. and Harrow Health, Inc. dated September 1, 2021
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2022
Asset Purchase Agreement between Novartis Technology LLC, Novartis Ophthalmics AG, and Harrow Health, Inc. (December 17, 2021)
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2022
Basic Sale and Purchase Agreement between Wakamoto Pharmaceutical Co., Ltd. and Harrow Health, Inc.
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2021
Loan and Security Agreement between Melt Pharmaceuticals, Inc. and Harrow Health, Inc. dated September 1, 2021
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2021
Securities Purchase Agreement between Harrow Health, Inc. and B. Riley Securities, Inc. dated May 5, 2021
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2021
First Supplemental Indenture to Indenture for 8.625% Senior Notes due 2026 between Harrow Health, Inc. and U.S. Bank National Association
Indenture Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2021
Indenture Agreement between Harrow Health, Inc. and U.S. Bank National Association (April 20, 2021)
Indenture Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2021
Business Loan Agreement under Paycheck Protection Program between Harrow Health, Inc. and Renasant Bank
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2020
Asset Purchase Agreement between Noice Rx, LLC and Park Compounding, Inc. dated July 26, 2019
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2019
Joinder and First Amendment to Loan and Security Agreement among SWK Funding LLC, Lenders, and Harrow Health, Inc. and Affiliates
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2019
Asset Purchase and License Agreement between Imprimis Pharmaceuticals, Inc. and Surface Pharmaceuticals, Inc.
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2018
Asset Purchase Agreement between Imprimis Pharmaceuticals, Inc. and Creative Pharmacy Solutions Central, LLC (Pharmacy Innovations)
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
PA
2017
Loan and Security Agreement among SWK Funding LLC, Lenders, and Imprimis Pharmaceuticals, Inc. and Affiliates (July 19, 2017)
Loan Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2017
Asset Purchase and License Agreement between Imprimis Pharmaceuticals, Inc. and Eton Pharmaceuticals, Inc. dated May 9, 2017
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2017
Asset Purchase and License Agreement between Imprimis Pharmaceuticals, Inc. and Eton Pharmaceuticals, Inc.
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2017
Securities Purchase Agreement between Imprimis Pharmaceuticals, Inc. and Buyers Dated March 21, 2017
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2017
Stock Purchase Agreement between Imprimis Pharmaceuticals, Inc., ImprimisRx TX, Inc., and Livernois & London, LLC
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2017
Amendment No. 2 to Warrant to Purchase Stock between Imprimis Pharmaceuticals, Inc. and IMMY Funding LLC
Warrant Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2016
Exchange and Discharge Agreement between Imprimis Pharmaceuticals, Inc. and IMMY Funding LLC
Exchange Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2016